We added the following clinical trials to Metastatic Trial Search for October 2024. To see all clinical trials, please visit Metastatic Trial Search.

ER or PR Positive Trials

• Stereotactic Body Radiation Therapy and FES PET/CT Scans for Oligoprogressive Metastatic ER+ Breast Cancer
• Saruparib PARP1 Inhibitor with Camizestrant Hormone Therapy for Advanced HR+, HER2- or HER2 Low Breast Cancer with BRCA1, BRCA2, or PALB2 Mutations

HER2 Negative Trials

• Eniluracil Targeted Therapy with Chemotherapy for Advanced HER2- Breast Cancer

Other Stage IV Trials

• QXL138AM Immunotherapy for Advanced Breast Cancer
• CID-078 Targeted Therapy for Advanced Breast Cancer
• MOMA-313 Targeted Therapy Alone or with PARP Inhibitor for Advanced Breast Cancer with HRD Mutations
• Immunotherapy and Radiation for Advanced CEA Positive Breast Cancer
• 177Lu-FAP-2286 Radioactive Drug for Advanced Breast Cancer
• Magnetic Resonance Fingerprinting to Distinguish Between Radiation Damage and Brain Tumor Progression

Last Modified on October 1, 2024